Paving the Way for a Minimal CHO ChassisExploring the Upper Limits of Megabase-Scale Deletions through DNA Repair Modulation
ACS Synthetic Biology · 2026
DOI: 10.1021/acssynbio.6c00460 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Melina Bräuer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Biotechnology, Biberach University of Applied Sciences, 88400Biberach an der Riss, Germany. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, DNA Repair, Sequence Deletion, Gene Editing. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Bundesministerium fur Forschung und Technologie, Bundesministerium für Forschung und Technologie.
Abstract (Originalsprache)
Chinese hamster ovary (CHO) cells are the predominant mammalian host for therapeutic protein production, yet their large genome contains substantial non-essential DNA that may impose metabolic burden and contribute to process variability. Here, we establish a CRISPR/Cas9-based strategy for megabase-scale genomic deletions in CHO cells, targeting regions from 3 to over 100 megabases (Mb). Clones carrying deletions of up to 50 Mb were isolated, while a candidate deletion junction spanning 130 Mb was detected in the edited pool, demonstrating the potential for large-scale genome engineering in mammalian cells. Importantly, removal of genomic regions with minimal coding content did not impair growth, viability, or monoclonal antibody productivity. Mechanistic analysis revealed rapid deletion formation and a size-dependent shift in DNA repair pathway usage. Transient inhibition of non-homologous end joining (NHEJ) significantly improved deletion efficiency and clone recovery without compromising cell fitness. These findings establish large-scale genome reduction as a feasible and controllable strategy for rational CHO genome streamlining and the development of next-generation biopharmaceutical cell factories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Applied Biotechnology, Biberach University of Applied Sciences, 88400Biberach an der Riss, Germany.
- Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400Biberach an der Riss, Germany.
ORCID-Profile: Melina Bräuer, Linus Weiß
Förderung
- Bundesministerium fur Forschung und Technologie
- Bundesministerium für Forschung und Technologie
Zitieren
APA
Bräuer, M., Walker, E., Schneider, S., Weiß, L., Geiger, A., Lindner, B., Hädicke, O., Schmidt, M., Fischer, S., & Otte, K. (2026). Paving the Way for a Minimal CHO ChassisExploring the Upper Limits of Megabase-Scale Deletions through DNA Repair Modulation. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00460
Vancouver
Bräuer M, Walker E, Schneider S, Weiß L, Geiger A, Lindner B, et al. Paving the Way for a Minimal CHO ChassisExploring the Upper Limits of Megabase-Scale Deletions through DNA Repair Modulation. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00460
BibTeX
@article{Bruer2026,
author = {Bräuer, Melina and Walker, Emely and Schneider, Stefan and Weiß, Linus and Geiger, Anna and Lindner, Benjamin and Hädicke, Oliver and Schmidt, Moritz and Fischer, Simon and Otte, Kerstin},
title = {Paving the Way for a Minimal CHO ChassisExploring the Upper Limits of Megabase-Scale Deletions through DNA Repair Modulation},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.6c00460}
}
EUVIMED